Markers of atherosclerosis in patients with Cushing’s syndrome: a meta-analysis of literature studies

References

• Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing's syndrome. Lancet. 2015;386:913–27.
   PubMed Web of Science ®Google Scholar
• Ferraù F, Korbonits M. Metabolic comorbidities in Cushing's syndrome. Eur J Endocrinol. 2015;173:M133–57.
   PubMed Web of Science ®Google Scholar
• Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A. Complications of Cushing's syndrome: state of the art. Lancet Diabetes Endocrinol. 2016;4:611–29.
   PubMed Web of Science ®Google Scholar
• de Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC, et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation. 2004;109:III33–8.
   PubMed Web of Science ®Google Scholar
• Baldassarre D, Hamsten A, Veglia F, de Faire U, Humphries SE, Smit A, et al. Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (carotid intima media thickness [IMT] and IMT-progression as predictors of vascular events in a high risk European population) study. J Am Coll Cardiol. 2012;60:1489–99.
   PubMed Web of Science ®Google Scholar
• Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–65.
   PubMed Web of Science ®Google Scholar
• Ras RT, Streppel MT, Draijer R, Zock PL. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol. 2013;168:344–51.
   PubMed Web of Science ®Google Scholar
• Petramala L, Lorenzo D, Iannucci G, Concistré A, Zinnamosca L, Marinelli C, et al. Subclinical atherosclerosis in patients with Cushing syndrome: evaluation with carotid intima-media thickness and ankle-brachial index. Endocrinol Metab (Seoul). 2015;30:488–93.
   PubMedGoogle Scholar
• Albiger N, Testa RM, Almoto B, Ferrari M, Bilora F, Petrobelli F, et al. Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors. Horm Metab Res. 2006;38:405–10.
   PubMed Web of Science ®Google Scholar
• Shivaprasad K, Kumar M, Dutta D, Sinha B, Mondal SA, Maisnam I, et al. Increased soluble TNF receptor-1 and glutathione peroxidase may predict carotid intima media thickness in females with Cushing syndrome. Endocr Pract. 2015;21:286–95.
   PubMed Web of Science ®Google Scholar
• Akaza I, Yoshimoto T, Tsuchiya K, Hirata Y. Endothelial dysfunction aassociated with hypercortisolism is reversible in Cushing's syndrome. Endocr J. 2010;57:245–52.
   PubMed Web of Science ®Google Scholar
• Jezková J, Marek J, Prázný M, Krsek M, Malíckov´ K, Rosická M, et al. Effect of hypercortisolism on development of atherosclerotic changes in blood vessels. Vnitr Lek. 2003;49:656–67.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2014. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj 2003;327:557–60.
   PubMed Web of Science ®Google Scholar
• Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323:101–05.
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–63.
   PubMed Web of Science ®Google Scholar
• Baykan M, Erem C, Gedikli O, Hacihasanoglu A, Erdogan T, Kocak M, et al. Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's syndrome. Endocrine. 2007;31:300–04.
   PubMed Web of Science ®Google Scholar
• Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, et al. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab. 1999;84:2664–72.
   PubMed Web of Science ®Google Scholar
• Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, et al. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab. 2003;88:2527–33.
   PubMed Web of Science ®Google Scholar
• Tauchmanovà L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab. 2002;87:4872–78.
   PubMed Web of Science ®Google Scholar
• Bassareo PP, Fanos V, Zaffanello M, Mercuro G. Early markers of cardiovascular dysfunction in young girls affected by Cushing's syndrome before and after successful cure. J Pediatr Endocrinol Metab. 2010;23:627–35.
   PubMed Web of Science ®Google Scholar
• Evran M, Akkuş G, Berk Bozdoğan İ, Gök M, Deniz A, Sert M, et al. Carotid intima-media thickness as the cardiometabolic risk indicator in patients with nonfunctional adrenal mass and metabolic syndrome screening. Med Sci Monit. 2016;22:991–97.
   PubMed Web of Science ®Google Scholar
• Wagenmakers M, Roerink S, Schreuder T, Plantinga TS, Holewijn S, Thijssen D, et al. Vascular health in patients in remission of Cushing's syndrome is comparable to that in BMI-matched controls. J Clin Endocrinol Metab. 2016;jc20161674; Aug 23 [Epub ahead of print].
   Web of Science ®Google Scholar
• Ozsurekci CG, Akturk M, Ozkan C, Gulbahar O, Altinova AE, Yalcin M, et al. Asymmetric dimethylarginine level and atherosclerosis markers in Cushing's syndrome. Endocr Pract. 2016;22:1088–95.
   PubMed Web of Science ®Google Scholar
• Reimondo G, Allasino B, Coletta M, Pia A, Peraga G, Zaggia B, et al. Evaluation of midnight salivary cortisol as a predictor factor for common carotid arteries intima media thickness in patients with clinically inapparent adrenal adenomas. Int J Endocrinol. 2015;2015:674734.
   PubMed Web of Science ®Google Scholar
• Ermetici F, Malavazos AE, Corbetta S, Eller-Vainicher C, Cannavò S, Corsi MM, et al. Soluble adhesion molecules levels in patients with Cushing's syndrome before and after cure. J Endocrinol Investig. 2008;31:389–92.
   PubMed Web of Science ®Google Scholar
• Kirilov G, Tomova A, Dakovska L, Kumanov P, Shinkov A, Alexandrov AS. Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing's syndrome. Eur J Endocrinol. 2003;149:549–53.
   PubMed Web of Science ®Google Scholar
• Cucina A, Borrelli V, Randone B, Coluccia P, Sapienza P, Cavallaro A. Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells. J Surg Res. 2003;109:16–23.
   PubMed Web of Science ®Google Scholar
• Zacharieva S, Atanassova I, Nachev E, Orbetzova M, Kirilov G, Kalinov K, et al. Markers of vascular function in hypertension due to Cushing's syndrome. Horm Metab Res. 2005;37:36–39.
   PubMed Web of Science ®Google Scholar
• Sudhir K, Jennings GL, Esler MD, Korner PI, Blombery PA, Lambert GW, et al. Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function. Hypertension. 1989;13:416–21.
   PubMed Web of Science ®Google Scholar
• Isidori AM, Graziadio C, Paragliola RM, Cozzolino A, Ambrogio AG, Colao A, et al. The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications. J Hypertens. 2015;33:44–60.
   PubMed Web of Science ®Google Scholar
• Wallerath T, Witte K, Schafer SC, Schwarz PM, Prellwitz W, Wohlfart P, et al. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA. 1999;96:13357–62.
   PubMed Web of Science ®Google Scholar
• Simmons WW, Ungureanu-Longrois D, Smith GK, Smith TW, Kelly RA. Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J Biol Chem. 1996; 271:23928–37.
   PubMed Web of Science ®Google Scholar
• Mitchell BM, Dorrance AM, Mack EA, Webb RC. Glucocorticoids decrease GTP cyclohydrolase and tetrahydrobiopterin-dependent vasorelaxation through glucocorticoid receptors. J Cardiovasc Pharmacol. 2004;43:8–13.
   PubMed Web of Science ®Google Scholar
• Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, et al. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res. 2003;92:81–87.
   PubMed Web of Science ®Google Scholar
• Stamler J, Pick R, Katz LN. Effects of cortisone, hydrocortisone and corticotropin on lipemia, glycemia and atherogenesis in cholesterol-fed chicks. Circulation. 1954;10:237–46.
   PubMed Web of Science ®Google Scholar
• Rosenfeld S, Marmorston J, Sobel H, White AE. Enhancement of experimental atherosclerosis by ACTH in the dog. Proc Soc Exp Biol Med. 1960;103:83–86.
   PubMed Web of Science ®Google Scholar
• Evans JF, Ragolia L. Systemic and local ACTH produced during inflammatory states promotes osteochondrogenic mesenchymal cell differentiation contributing to the pathologic progression of calcified atherosclerosis. Med Hypotheses. 2012;79:823–26.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Shibata H, Ando T, Kurihara I, Kobayashi S, Hayashi K, et al. Risk factors associated with persistent postoperative hypertension in Cushing's syndrome. Endocr Res. 2000;26:791–95.
   PubMed Web of Science ®Google Scholar
• van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam study. Circulation. 2004;109:1089–94.
   PubMed Web of Science ®Google Scholar
• Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Di Minno MN. Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies. Thromb Haemost. 2015;113:916–30.
   PubMed Web of Science ®Google Scholar
• Shimbo D, Grahame-Clarke C, Miyake Y, Rodriguez C, Sciacca R, Di Tullio M, et al. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis. 2007;192:197–203.
   PubMed Web of Science ®Google Scholar
• Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, et al. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2014;2:396–405.
   PubMed Web of Science ®Google Scholar
• Di Minno MN, Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, et al. Clinical assessment of endothelial function in patients with rheumatoid arthritis: a meta-analysis of literature studies. Eur J Intern Med. 2015;26:835–42.
   PubMed Web of Science ®Google Scholar
• Di Minno MN, Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, et al. Cardiovascular risk markers in patients with psoriatic arthritis: a meta-analysis of literature studies. Ann Med. 2015;47:346–53.
   PubMed Web of Science ®Google Scholar